These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 34245901)

  • 21. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
    Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
    Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
    Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clostridioides difficile - New Insights and Therapy Recommendations].
    Schönherr S; Jung L; Lübbert C
    Dtsch Med Wochenschr; 2023 Jun; 148(12):752-758. PubMed ID: 37257477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
    Chauhan A; Apostolov R; van Langenberg D; Garg M
    Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.
    Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T
    J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and treatment of recurrent Clostridioides difficile infection.
    Shin JH; Warren CA
    Curr Opin Infect Dis; 2019 Oct; 32(5):482-489. PubMed ID: 31369420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbid status and the faecal microbial transplantation failure in treatment of recurrent Clostridioides difficile infection - pilot prospective observational cohort study.
    Kachlíková M; Sabaka P; Koščálová A; Bendžala M; Dovalová Z; Stankovič I
    BMC Infect Dis; 2020 Jan; 20(1):52. PubMed ID: 31948404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecal microbiota transplantation as a home therapy to frail older people.
    Jørgensen SMD; Rubak TMM; Damsgaard EM; Dahlerup JF; Hvas CL
    Age Ageing; 2020 Oct; 49(6):1093-1096. PubMed ID: 32365381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal microbiota transplantation for treatment of recurrent or refractory
    Lui RN; Wong SH; Lau LHS; Chan TT; Cheung KCY; Li A; Chin ML; Tang W; Ching JYL; Lam KLY; Chan PKS; Wu JCY; Sung JJY; Chan FKL; Ng SC
    Hong Kong Med J; 2019 Jun; 25(3):178-182. PubMed ID: 31178437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent
    Alhifany AA; Almutairi AR; Almangour TA; Shahbar AN; Abraham I; Alessa M; Alnezary FS; Cheema E
    BMJ Open; 2019 Nov; 9(11):e031145. PubMed ID: 31699731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis.
    Konijeti GG; Sauk J; Shrime MG; Gupta M; Ananthakrishnan AN
    Clin Infect Dis; 2014 Jun; 58(11):1507-14. PubMed ID: 24692533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Tariq R; Saha S; Solanky D; Pardi DS; Khanna S
    J Clin Gastroenterol; 2021 Jul; 55(6):542-547. PubMed ID: 32701563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention.
    Lavoie T; Appaneal HJ; LaPlante KL
    Clin Infect Dis; 2023 Dec; 77(Suppl 6):S447-S454. PubMed ID: 38051964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
    Orenstein R; Dubberke ER; Khanna S; Lee CH; Yoho D; Johnson S; Hecht G; DuPont HL; Gerding DN; Blount KF; Mische S; Harvey A
    BMC Infect Dis; 2022 Mar; 22(1):245. PubMed ID: 35279084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of bezlotoxumab to prevent recurrent Clostridioides difficile infection (CDI) in patients with multiple prior recurrent CDI.
    Skinner AM; Tan X; Westman C; Birris T; Drwiega EN; Wang MS; Johnson S
    Anaerobe; 2023 Dec; 84():102788. PubMed ID: 37931679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis.
    Tariq R; Hayat M; Pardi D; Khanna S
    Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1383-1392. PubMed ID: 33496893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and future trends in clostridioides (clostridium) difficile infection management.
    Khanna S; Gerding DN
    Anaerobe; 2019 Aug; 58():95-102. PubMed ID: 31054313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection.
    Luo Y; Lucas AL; Grinspan AM
    Dig Dis Sci; 2020 Apr; 65(4):1125-1133. PubMed ID: 31493042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.